Histone deacetylases (HDACs) regulate the expression and activity of numerous proteins involved in the initiation and progression of cancer. Currently, three hydroxamate-containing HDAC pan-inhibitors have been approved as antitumor agents.

Brindisi, M., Cavella, C., Brogi, S., Nebbioso, A., Senger, J., Maramai, S., et al. (2016). Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies. FUTURE MEDICINAL CHEMISTRY, 8(13), 1573-1587 [10.4155/fmc-2016-0068].

Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies

CAVELLA, CATERINA;MARAMAI, SAMUELE;BUTINI, STEFANIA;LAMPONI, STEFANIA;CAMPIANI, GIUSEPPE;GEMMA, SANDRA
2016-01-01

Abstract

Histone deacetylases (HDACs) regulate the expression and activity of numerous proteins involved in the initiation and progression of cancer. Currently, three hydroxamate-containing HDAC pan-inhibitors have been approved as antitumor agents.
2016
Brindisi, M., Cavella, C., Brogi, S., Nebbioso, A., Senger, J., Maramai, S., et al. (2016). Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies. FUTURE MEDICINAL CHEMISTRY, 8(13), 1573-1587 [10.4155/fmc-2016-0068].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/995522